kidney failure semaglutide Novo Nordisk's Ozempic Gets FDA Approval as Kidney-Disease Treatment A popular diabetes medication has

Our findings suggest that a randomised controlled trial of GLP-1 receptor agonist use in people with diabetes and depression, anxiety, or both would be worthwhile. Professor Mark Taylor from Griffith University, and one of the studys authors, said: An earlier study examining Swedish registers found the use of GLP-1 medications to be associated with a reduced risk of alcohol use disorder

This milk thistle skin care hack was brought to the cast

However, this slower digestion can disrupt your guts rhythm, leading to digestive issues like diarrhea, bloating, and nausea

Its important to remember that everyones body is different, so results can vary

Gastrointestinal adverse events Compared with placebo, all doses of tirzepatide and semaglutide demonstrated an increase in the risk for nausea (ESM Fig